Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration-Reference-Cited by-同舟云学术

Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration

Published:2018-05-24 Issue:4 Volume:1 Page:159-173
ISSN:2515-2084
Container-title:Journal of the Canadian Association of Gastroenterology
language:en
Short-container-title:

Author:

Kuenzig M Ellen¹^ORCID,Rezaie Ali²,Kaplan Gilaad G³⁴,Otley Anthony R⁵,Steinhart A Hillary⁶,Griffiths Anne Marie⁷,Benchimol Eric I¹⁸^ORCID,Seow Cynthia H³⁴^ORCID

Affiliation:

1. CHEO Inflammatory Bowel Disease Centre, Division of Gastroenterology Hepatology & Nutrition, Children’s Hospital of Eastern Ontario, Ontario, Ottawa, Canada

2. Department of Medicine, Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, California, USA

3. Department of Medicine, University of Calgary, Calgary, Canada

4. Department of Community Health Sciences, University of Calgary, Calgary, Canada

5. Division of Gastroenterology, IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada

6. Department of Medicine, Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada

7. Division of Gastroenterology, Hepatology & Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada

8. Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada

Funder

Canadian Institutes of Health Research

Ontario Ministry of Health and Long-Term Care

Publisher

Oxford University Press (OUP)

Link

http://academic.oup.com/jcag/article-pdf/1/4/159/28695663/gwy018.pdf

Reference49 articles.

1. Inflammatory bowel disease: Clinical aspects and established and evolving therapies;Baumgart;Lancet,2007

2. Inflammatory bowel disease;Hyams;Pediatr Rev,2005

3. Immunosuppressant medications and mortality in inflammatory bowel disease;Lewis;Am J Gastroenterol,2008

4. Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide;Fedorak;Advanced Drug Delivery Reviews,2005

5. Budesonide for maintenance of remission in Crohn’s disease;Kuenzig;Cochrane Database Syst Rev,2014

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocaecal resection for Crohn's disease: A retrospective analysis of 853 consecutive patients;Digestive and Liver Disease;2024-09

2. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

3. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

4. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment;Journal of Crohn's and Colitis;2024-06-15

5. Medical Management of Inflammatory Bowel Disease;Surgical Clinics of North America;2024-06